Our Services
Medical Information
Helpful Resources
Published on: 4/21/2026
Horizant (gabapentin enacarbil) is an extended release form of gabapentin approved for restless legs syndrome and postherpetic neuralgia that shows promise as a once daily treatment for diabetic peripheral neuropathy by providing steadier blood levels to reduce burning, tingling and nighttime flare ups. Early evidence suggests it may improve sleep quality and daily function compared with multiple daily doses of immediate release gabapentin.
Important information on dosing schedules, side effects, safety considerations and comparisons with other therapies can be found below and may influence your next steps in managing diabetic nerve pain.
Diabetic peripheral neuropathy (DPN) can cause burning, tingling or stabbing pain in the hands and feet. Many people with diabetes find their daily lives impacted by nerve pain that disrupts sleep, walking and mood. Horizant (gabapentin enacarbil) is an extended-release form of gabapentin approved by the FDA to manage moderate to severe restless legs syndrome and postherpetic neuralgia. Emerging evidence suggests it may also help ease diabetic nerve pain. Below, we'll explore how Horizant works, its potential benefits and important safety considerations for using Horizant for diabetic pain.
Diabetic peripheral neuropathy arises when high blood sugar levels damage small nerve fibers. Common symptoms include:
Left untreated, DPN can interfere with daily activities, sleep quality and overall well-being. Early recognition and treatment are key to preventing complications such as foot ulcers.
Horizant contains gabapentin enacarbil, a prodrug converted into gabapentin after absorption. Its extended-release design aims for:
Originally studied for restless legs syndrome, researchers have explored Horizant's role in other neuropathic pain conditions, including diabetic nerve pain.
Gabapentin modulates calcium channels on nerve cells. By reducing excessive electrical activity in damaged nerves, it can:
Horizant's extended-release formulation helps maintain stable gabapentin levels, which may translate into smoother pain relief for those using Horizant for diabetic pain.
While gabapentin immediate release is widely prescribed off-label for DPN, specific trials of gabapentin enacarbil are more limited. Key findings include:
Overall, Horizant shows promise as an alternative to immediate-release formulations, especially for patients seeking once‐ or twice‐daily dosing.
Convenient Dosing
Consistent Pain Control
Well-Studied Mechanism
Potential Quality-of-Life Gains
As with any medication, Horizant carries potential risks. The most frequent side effects include:
Less common but serious warnings:
Tips to improve safety:
Always discuss your full medical history—including kidney function, respiratory status and current medications—with your doctor before starting Horizant.
A typical dosing schedule for Horizant when used off-label for diabetic neuropathy may mirror approved uses:
Your healthcare provider will tailor the dose based on:
Never split, crush or chew the tablets—swallow them whole to preserve the extended-release properties.
Horizant for diabetic pain offers an alternative to several common options:
Choosing the right therapy involves balancing efficacy, side effects, dosing convenience and personal health goals.
Horizant for diabetic pain may be suited to patients who:
It's not recommended for pregnant or breastfeeding individuals, those with significant respiratory disease, or patients with severe kidney impairment without dose adjustments.
If you're experiencing burning, tingling or numbness and want to understand what might be causing your discomfort, Ubie's Medically approved LLM Symptom Checker Chat Bot can help you identify potential conditions and determine whether you should seek professional care—it's free, quick and available 24/7.
Always consult your healthcare provider before starting, stopping or changing any medication. Seek immediate medical attention if you experience:
For ongoing diabetic pain, work closely with your doctor to develop a comprehensive plan that may include blood sugar control, lifestyle measures and medication like Horizant.
Horizant (gabapentin enacarbil) offers a promising once-daily option for people suffering from diabetic peripheral neuropathy. Its extended-release formula can provide steadier pain relief, improved sleep and a potential reduction in the need for multiple daily doses. By understanding its benefits, risks and proper use, you can make an informed decision about whether Horizant for diabetic pain could fit into your treatment plan. Always discuss any serious or life-threatening concerns with your doctor. With the right approach, relief from diabetic nerve pain is within reach.
(References)
* Schwartz SL, Versavel M, Johnson P, et al. Gabapentin enacarbil in the treatment of postherpetic neuralgia: a phase 3, randomized, double-blind, placebo-controlled trial. *J Pain*. 2013 Aug;14(8):844-55. doi: 10.1016/j.jpain.2013.02.007. Epub 2013 Apr 20. PMID: 23740266.
* Chen C, Gu D, Liu H, Wang J. Gabapentin enacarbil extended-release for the treatment of moderate-to-severe primary restless legs syndrome: A meta-analysis. *J Clin Pharm Ther*. 2018 Dec;43(6):793-802. doi: 10.1111/jcpt.12720. Epub 2018 Jun 18. PMID: 29916174.
* Zuniga J, Laux L, Sisk CM, Bieszk N, Pleshko AM. Gabapentin enacarbil extended-release for treatment of postherpetic neuralgia: a review of efficacy, safety, and patient selection. *Pain Ther*. 2013 Dec;2(2):101-14. doi: 10.1007/s40122-013-0017-8. Epub 2013 Aug 31. PMID: 24204558; PMCID: PMC3931693.
* Zhu Y, Yang B, Feng Y, et al. Efficacy and Safety of Gabapentin Enacarbil for the Treatment of Primary Restless Legs Syndrome: A Systematic Review and Meta-Analysis. *Neurol Ther*. 2021 Jun;10(3):1219-1234. doi: 10.1007/s40120-021-00262-1. Epub 2021 May 29. PMID: 34050962; PMCID: PMC8164082.
* Wang M, Peng X, Lv J, Liu Y. Gabapentin enacarbil for the treatment of postherpetic neuralgia: a meta-analysis of randomized placebo-controlled trials. *Pain Physician*. 2014 Mar-Apr;17(2):E161-8. PMID: 24658485.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.